June 19 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab said on Wednesday that it has rejected takeover offers from UK-based Cycle Pharmaceutical and a revised bid from contract ...

(Reuters) - Vanda Pharmaceuticals Inc (VNDA.O), opens new tab has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed ...

Vanda Pharmaceuticals (NASDAQ:VNDA) is alleging that members of the U.S. FDA "have committed to delay" its request for a hearing to discuss the agency's issuing of a Complete Response Letter in ...

Vanda Pharmaceuticals has scored a legal win in its long-running dispute with the FDA surrounding the agency's 2018 rejection of Hetlioz in jet lag disorder. After months of litigation and years ...

Vanda Pharmaceuticals has been waiting years for an FDA hearing to contest the agency’s 2019 rejection of its sleep drug Hetlioz in jet lag disorder. Now, following a lawsuit and a protracted ...

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug ...

EXCLUSIVE: Crime heist drama series Vanda is headed to Hulu. The U.S. streamer will be the exclusive SVOD home to the series, an international co-production from Legendary, indie producer SPi and ...

WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market closes.